BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15895231)

  • 1. Augmenting tumor sensitivity to topotecan by transient hypoxia.
    Lund EL; Hansen LT; Kristjansen PE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):473-80. PubMed ID: 15895231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice.
    Chastagner P; Kozin SV; Taghian A
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):777-82. PubMed ID: 11395247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
    Koshikawa N; Takenaga K
    Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
    Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
    Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of dexamethasone on Lewis mice lung cancer cells.
    Geng Y; Wang J; Jing H; Wang HW; Bao YX
    Genet Mol Res; 2014 Aug; 13(3):6827-36. PubMed ID: 25177962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?
    Kim JA; Kim SJ; Do IG; Jin J; Nam DH; Ko YH; Kim K; Kim WS
    Leuk Lymphoma; 2011 Feb; 52(2):205-13. PubMed ID: 21281236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts.
    Rapisarda A; Zalek J; Hollingshead M; Braunschweig T; Uranchimeg B; Bonomi CA; Borgel SD; Carter JP; Hewitt SM; Shoemaker RH; Melillo G
    Cancer Res; 2004 Oct; 64(19):6845-8. PubMed ID: 15466170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
    Birle DC; Hedley DW
    Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial NO synthase and reactive oxygen species mediated effect of simvastatin on vessel structure and function: pleiotropic and dose-dependent effect on tumor vascular stabilization.
    Chen Y; Zhang S; Peng G; Yu J; Liu T; Meng R; Li Z; Zhao Y; Wu G
    Int J Oncol; 2013 Apr; 42(4):1325-36. PubMed ID: 23426387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1alpha modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines.
    Choi YJ; Rho JK; Lee SJ; Jang WS; Lee SS; Kim CH; Lee JC
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1047-53. PubMed ID: 19148680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma.
    Lund EL; Høg A; Olsen MW; Hansen LT; Engelholm SA; Kristjansen PE
    Int J Cancer; 2004 Mar; 108(6):833-8. PubMed ID: 14712484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression.
    Büchler P; Reber HA; Büchler MW; Friess H; Lavey RS; Hines OJ
    Cancer; 2004 Jan; 100(1):201-10. PubMed ID: 14692041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of hypoxia-inducible factor-1 alpha in RPMI8226 myeloma cells results in reduced tumor growth in nude mice].
    Li BZ; Zhuang WZ; Chen P; Fu JX
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):247-51. PubMed ID: 18843979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antioxidant N-acetylcysteine prevents HIF-1 stabilization under hypoxia in vitro but does not affect tumorigenesis in multiple breast cancer models in vivo.
    Sceneay J; Liu MC; Chen A; Wong CS; Bowtell DD; Möller A
    PLoS One; 2013; 8(6):e66388. PubMed ID: 23840457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
    Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
    Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
    Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.